Prime Medicine, Inc.

PRME ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Assets
Cash & Equivalents $55.6M $94.2M $41.6M $44.0M $120.6M $133.5M $187.6M $47.9M
Accounts Receivable
Inventory
Total Current Assets $170.8M $217.7M $143.0M $184.5M $218.5M $253.5M $296.6M $148.8M
Property, Plant & Equipment $23.8M $23.9M $22.7M $22.0M $20.6M $21.6M $19.0M $15.0M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $259.7M $311.4M $193.9M $239.1M $280.9M $316.9M $360.3M $215.3M
Liabilities
Accounts Payable $4.6M $10.1M $19.5M $14.1M $5.5M $4.6M $4.3M $4.1M
Total Current Liabilities $20.7M $24.4M $56.4M $39.4M $28.7M $23.9M $26.7M $22.2M
Long-Term Debt
Total Liabilities $63.1M $67.6M $60.8M $45.2M $40.8M $38.1M $44.0M $42.6M
Stockholders' Equity
Retained Earnings $-592.4M $-537.1M $-491.3M $-425.7M $-375.0M $-332.6M $-293.2M $-253.9M
Total Stockholders' Equity $196.6M $243.8M $133.1M $194.0M $240.1M $278.8M $316.3M $-223.1M
← Newer Page 2 of 3 Older →
Charlie Munger

Focus on wisdom, rationality, learning, and avoiding stupidity in life and investing.